RP
REGENERON PHARMACEUTICALS
REGN· Health Care· BiotechnologyS&P 500
Close · 26/10/2026
807.67
1D
+0.33%52-week range
575.93 – 859.34
Volume
4,23,900.00
Price history
REGN
25/09/2026 to 26/10/2026
O 812.31 H 817.17 L 796.61
1W+3.28%
1M+2.49%
3M+16.18%
6M+8.49%
1Y+40.30%
3Y-0.12%
5Y+48.61%
MAX+21.04%
Fundamentals
as of 26/10/2026- Market cap
- $75.88B
- Shares out
- 93.96M
- P/E (trailing)
- 17.53
- P/E (forward)
- 12.84
- EPS (trailing)
- 46.07
- Dividend yield
- 0.46%
- Beta
- 0.15
- Profit margin
- 27.86%
- P/B
- 2.39
- Return on equity
- 13.65%
SEC financial statements
63 quarterly and 18 annual periods through 30/06/2026.
Details
- Ticker
- REGN
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 26/10/2026.
Tracked by Congress
12 filers · 2 on watchlist · 12 buys · 22 sells · ?: 1 · D: 25 · R: 8
- 27/03/2026Alan ArmstrongBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 15/05/2026Gilbert CisnerosSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 12/02/2026Julia LetlowBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 18/11/2025Gilbert CisnerosBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 15/05/2025Rob BresnahanBuyRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 10/04/2025Byron DonaldsSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 10/04/2025Byron DonaldsSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 01/04/2025Julie JohnsonSellRegeneron Pharmaceuticals, Inc. - Common Stock$1,001–$15,000